Is Reddit a Buy on the Dip?
Reddit (NYSE:RDDT) share price has been on the proverbial ropes…
Sell
45
EMBC Quote, Financials, Valuation and Earnings
Last price:
$13.17
Seasonality move
:
-13.41%
Day range:
$12.76 - $13.30
52-week range:
$9.93 - $21.48
Dividend yield:
4.56%
P/E ratio:
13.15x
P/S ratio:
0.69x
P/B ratio:
--
Volume:
675.7K
Avg. volume:
618K
1-year change:
-4.36%
Market cap:
$764.5M
Revenue:
$1.1B
EPS (TTM):
$1.00
Analysts' Opinion
-
Consensus RatingEmbecta has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.00, Embecta has an estimated upside of 67.3% from its current price of $13.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.00 representing 100% downside risk from its current price of $13.15.
Fair Value
-
According to the consensus of 3 analysts, Embecta has 67.3% upside to fair value with a price target of $22.00 per share.
EMBC vs. S&P 500
-
Over the past 5 trading days, Embecta has overperformed the S&P 500 by 5.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Embecta does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Embecta revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Embecta reported revenues of $261.9M.
Earnings Growth
-
Embecta earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Embecta reported earnings per share of --.
Enterprise value:
2.1B
EV / Invested capital:
--
Price / LTM sales:
0.69x
EV / EBIT:
14.81x
EV / Revenue:
1.89x
PEG ratio (5yr expected):
2.50x
EV / Free cash flow:
72.62x
Price / Operating cash flow:
26.52x
Enterprise value / EBITDA:
11.62x
Gross Profit (TTM):
$706.4M
Return On Assets:
4.76%
Net Income Margin (TTM):
5.25%
Return On Equity:
--
Return On Invested Capital:
7.12%
Operating Margin:
14.93%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.1B | $277.3M | $261.9M | |
| Gross Profit | $759.8M | $747M | $706.4M | $185.9M | $157.1M | |
| Operating Income | $340.7M | $307.3M | $278.6M | $73.8M | $39.1M | |
| EBITDA | $298.4M | $207.6M | $180.6M | $51.2M | $39.1M | |
| Diluted EPS | $2.76 | $0.95 | $1.00 | $0.35 | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $258.3M | $761.7M | $719.5M | $667.2M | |
| Total Assets | -- | $739.9M | $1.2B | $1.2B | $1.1B | |
| Current Liabilities | -- | $159.1M | $370.3M | $326.6M | $298.2M | |
| Total Liabilities | -- | $189.4M | $2B | $2B | $1.9B | |
| Total Equity | -- | $550.5M | -$836.1M | -$793.5M | -$768.8M | |
| Total Debt | -- | -- | $1.6B | $1.6B | $1.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $333.8M | -$5.8M | $43.5M | -$13.1M | -$5.3M | |
| Cash From Investing | -$24.4M | -$24.5M | -$14.6M | -$2.7M | -$1.5M | |
| Cash From Financing | $80.4M | -$56.1M | -$105.1M | -$13.5M | -$45.2M | |
| Free Cash Flow | $309.4M | -$30.3M | $28.9M | -$15.8M | -$6.8M | |
EMBC
Sector
Market Cap
$764.5M
$38.4M
Price % of 52-Week High
61.22%
45.53%
Dividend Yield
4.56%
0%
Shareholder Yield
--
-0.78%
1-Year Price Total Return
-4.36%
-39.05%
Beta (5-Year)
--
0.774
Dividend yield:
4.56%
Annualized payout:
$0.60
Payout ratio:
59.62%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$13.16
200-day SMA
Sell
Level
$15.43
Bollinger Bands (100)
Sell
Level
14.13 - 19.73
Chaikin Money Flow
Sell
Level
-24.1M
20-day SMA
Sell
Level
$13.96
Relative Strength Index (RSI14)
Sell
Level
37.46
ADX Line
Sell
Level
41.03
Williams %R
Neutral
Level
-56.71
50-day SMA
Sell
Level
$17.04
MACD (12, 26)
Sell
Level
-1.12
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Sell
Level
-37.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3351)
Sell
CA Score
(Annual)
Level (-4.7088)
Sell
Beneish M-Score
(Annual)
Level (7.5103)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (6.3751)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Stock Forecast FAQ
In the current month, EMBC has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The EMBC average analyst price target in the past 3 months is $22.00.
-
Where Will Embecta Stock Be In 1 Year?
According to analysts, the consensus estimate is that Embecta share price will rise to $22.00 per share over the next 12 months.
-
What Do Analysts Say About Embecta?
Analysts are divided on their view about Embecta share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Embecta is a Sell and believe this share price will drop from its current level to $20.00.
-
What Is Embecta's Price Target?
The price target for Embecta over the next 1-year time period is forecast to be $22.00 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is EMBC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Embecta is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EMBC?
You can purchase shares of Embecta via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Embecta shares.
-
What Is The Embecta Share Price Today?
Embecta was last trading at $13.17 per share. This represents the most recent stock quote for Embecta. Yesterday, Embecta closed at $13.15 per share.
-
How To Buy Embecta Stock Online?
In order to purchase Embecta stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Qualcomm Stock: 5G Leader at a Bargain Price?
Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…
What Is Buffett Buying and Selling Now?
In Q4 of last year, Warren Buffett made a few…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
59
GRRR alert for Mar 15
Gorilla Technology Group [GRRR] is up 29.72% over the past day.
Sell
49
SMTC alert for Mar 15
Semtech [SMTC] is up 21.28% over the past day.
Buy
62
PLPC alert for Mar 15
Preformed Line Products [PLPC] is up 17.38% over the past day.
